Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions

Human induced pluripotent stem cells (hiPSCs) hold great promise for cardiovascular regeneration following ischemic injury. Considerable effort has been made toward the development and optimization of methods to differentiate hiPSCs into vascular cells, such as endothelial and smooth muscle cells (E...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jee Eun Oh, Cholomi Jung, Young-sup Yoon
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/09ffb386a6834076a432c3504635c24b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:09ffb386a6834076a432c3504635c24b
record_format dspace
spelling oai:doaj.org-article:09ffb386a6834076a432c3504635c24b2021-11-25T18:00:21ZHuman Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions10.3390/jcdd81101482308-3425https://doaj.org/article/09ffb386a6834076a432c3504635c24b2021-11-01T00:00:00Zhttps://www.mdpi.com/2308-3425/8/11/148https://doaj.org/toc/2308-3425Human induced pluripotent stem cells (hiPSCs) hold great promise for cardiovascular regeneration following ischemic injury. Considerable effort has been made toward the development and optimization of methods to differentiate hiPSCs into vascular cells, such as endothelial and smooth muscle cells (ECs and SMCs). In particular, hiPSC-derived ECs have shown robust potential for promoting neovascularization in animal models of cardiovascular diseases, potentially achieving significant and sustained therapeutic benefits. However, the use of hiPSC-derived SMCs that possess high therapeutic relevance is a relatively new area of investigation, still in the earlier investigational stages. In this review, we first discuss different methodologies to derive vascular cells from hiPSCs with a particular emphasis on the role of key developmental signals. Furthermore, we propose a standardized framework for assessing and defining the EC and SMC identity that might be suitable for inducing tissue repair and regeneration. We then highlight the regenerative effects of hiPSC-derived vascular cells on animal models of myocardial infarction and hindlimb ischemia. Finally, we address several obstacles that need to be overcome to fully implement the use of hiPSC-derived vascular cells for clinical application.Jee Eun OhCholomi JungYoung-sup YoonMDPI AGarticlehuman induced pluripotent stem cellendothelial cellsmooth muscle cellstem cellcardiovascular diseaseregenerative medicineDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of Cardiovascular Development and Disease, Vol 8, Iss 148, p 148 (2021)
institution DOAJ
collection DOAJ
language EN
topic human induced pluripotent stem cell
endothelial cell
smooth muscle cell
stem cell
cardiovascular disease
regenerative medicine
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle human induced pluripotent stem cell
endothelial cell
smooth muscle cell
stem cell
cardiovascular disease
regenerative medicine
Diseases of the circulatory (Cardiovascular) system
RC666-701
Jee Eun Oh
Cholomi Jung
Young-sup Yoon
Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions
description Human induced pluripotent stem cells (hiPSCs) hold great promise for cardiovascular regeneration following ischemic injury. Considerable effort has been made toward the development and optimization of methods to differentiate hiPSCs into vascular cells, such as endothelial and smooth muscle cells (ECs and SMCs). In particular, hiPSC-derived ECs have shown robust potential for promoting neovascularization in animal models of cardiovascular diseases, potentially achieving significant and sustained therapeutic benefits. However, the use of hiPSC-derived SMCs that possess high therapeutic relevance is a relatively new area of investigation, still in the earlier investigational stages. In this review, we first discuss different methodologies to derive vascular cells from hiPSCs with a particular emphasis on the role of key developmental signals. Furthermore, we propose a standardized framework for assessing and defining the EC and SMC identity that might be suitable for inducing tissue repair and regeneration. We then highlight the regenerative effects of hiPSC-derived vascular cells on animal models of myocardial infarction and hindlimb ischemia. Finally, we address several obstacles that need to be overcome to fully implement the use of hiPSC-derived vascular cells for clinical application.
format article
author Jee Eun Oh
Cholomi Jung
Young-sup Yoon
author_facet Jee Eun Oh
Cholomi Jung
Young-sup Yoon
author_sort Jee Eun Oh
title Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions
title_short Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions
title_full Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions
title_fullStr Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions
title_full_unstemmed Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions
title_sort human induced pluripotent stem cell-derived vascular cells: recent progress and future directions
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/09ffb386a6834076a432c3504635c24b
work_keys_str_mv AT jeeeunoh humaninducedpluripotentstemcellderivedvascularcellsrecentprogressandfuturedirections
AT cholomijung humaninducedpluripotentstemcellderivedvascularcellsrecentprogressandfuturedirections
AT youngsupyoon humaninducedpluripotentstemcellderivedvascularcellsrecentprogressandfuturedirections
_version_ 1718411722998415360